Jiewei Wang

机构：Qiqihar University, Wenzhou Medical University, Zhejiang Taizhou Hospital, First Affiliated Hospital Zhejiang University, Taizhou University · ORCID：0009-0002-8184-7926

发表论文 41 篇 · 总被引 549 次 · h-index 12

代表论文

• USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice (2023 · Nature Communications · 被引 67)
• Advances in the application of Let‑7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review) (2021 · Oncology Letters · 被引 34)
• Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity (2022 · Signal Transduction and Targeted Therapy · 被引 25)
• The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells (2021 · Journal of Biological Chemistry · 被引 14)
• Control measures to prevent Coronavirus disease 2019 pandemic in endoscopy centers: Multi‐center study (2020 · Digestive Endoscopy · 被引 12)
• The deubiquitinase USP28 maintains the expression of PPARγ and its inactivation protects mice from diet-induced MASH and hepatocarcinoma (2025 · Molecular Therapy · 被引 7)